Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Mapping the Responses to COVID-19 Vaccination in Patients With Cancer - the ReCOVer Study

NCT04745377 is registered in ClinicalTrials.gov with Hellenic Cooperative Oncology Group as lead sponsor.

NCT NCT04745377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04745377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Mapping the Responses to COVID-19 Vaccination in Patients With Cancer - the ReCOVer Study
Lead sponsor
Hellenic Cooperative Oncology Group
Phase
Observational
Overall status
Completed
Start date
January 12, 2021
Completion date
May 20, 2022
Enrollment
332 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cancer